论文信息 - A Rare Cause of Recurrent Febrile Encephalopathy in a Child: The Expanding Spectrum of ATP1A3 Mutations

A Rare Cause of Recurrent Febrile Encephalopathy in a Child: The Expanding Spectrum of ATP1A3 Mutations

ATP1A3 mutations have been recognized in infants and children presenting with a diverse group of neurological phenotypes, including rapid-onset dystonia parkinsonism (RDP), alternating hemiplegia of childhood (AHC), and cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss (CAPOS) syndrome. A new phenotype of fever-induced paroxysmal muscle weakness and encephalopathy (FIPWE) in patients with ATP1A3 mutations at c.2267G>A p residue 756H has been described most recently in few cases. Here, we report an additional case with an ATP1A3 mutation at c.2267G>A p residue 756H presenting with fever-induced paroxysmal muscle weakness and encephalopathy. To the best of our knowledge, this is the first reported case from the Middle East. This 18-month-old boy presented with recurrent, reversible fever-induced episodes of seizures, central hypotonia, areflexia, and developmental regression. The mainstay management for patients with ATP1A3 related diseases is symptomatic treatment as there is no specific proposed treatment. Aggressive management of febrile illness may be helpful in alleviating the symptoms.

A. Abdalla | N. Chencheri | Saja Tahir | Mohamed O E Babiker

[1] K. Swoboda,et al. Fever-Induced Paroxysmal Weakness and Encephalopathy, a New Phenotype of ATP1A3 Mutation. , 2017, Pediatric neurology.

[2] A. Duat Rodríguez,et al. Early Diagnosis of CAPOS Syndrome Before Acute-Onset Ataxia-Review of the Literature and a New Family. , 2017, Pediatric neurology.

[3] Frederick Andermann,et al. Research conference summary from the 2014 International Task Force on ATP1A3-Related Disorders , 2017, Neurology: Genetics.

[4] Bart P C van de Warrenburg,et al. The Genetic Homogeneity of CAPOS Syndrome: Four New Patients With the c.2452G>A (p.Glu818Lys) Mutation in the ATP1A3 Gene. , 2016, Pediatric neurology.

[5] K. Swoboda,et al. ATP1A3-Related Neurologic Disorders , 2014 .

[6] E. Veneselli,et al. Paroxysmal features responding to flunarizine in a child with rapid-onset dystonia-parkinsonism , 2014, Neurology.

[7] Mohamad A Mikati,et al. Distinct neurological disorders with ATP1A3 mutations , 2014, The Lancet Neurology.

[8] Allison Brashear,et al. ATP1A3 mutations in infants: a new rapid‐onset dystonia–Parkinsonism phenotype characterized by motor delay and ataxia , 2012, Developmental medicine and child neurology.